Nantahala Capital Management’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-111,148
| Closed | -$1.37M | – | 137 |
|
|
2023
Q2 | $1.37M | Sell |
111,148
-80,118
| -42% | -$985K | 0.13% | 72 |
|
|
2023
Q1 | $2.35M | Sell |
191,266
-18,734
| -9% | -$230K | 0.18% | 62 |
|
|
2022
Q4 | $2.41M | Sell |
210,000
-219,596
| -51% | -$2.52M | 0.16% | 63 |
|
|
2022
Q3 | $1.61M | Sell |
429,596
-61,913
| -13% | -$232K | 0.1% | 66 |
|
|
2022
Q2 | $2.92M | Sell |
491,509
-25,308
| -5% | -$151K | 0.15% | 61 |
|
|
2022
Q1 | $3.27M | Sell |
516,817
-53,154
| -9% | -$336K | 0.14% | 61 |
|
|
2021
Q4 | $2.23M | Hold |
569,971
| – | – | 0.08% | 80 |
|
|
2021
Q3 | $2.75M | Sell |
569,971
-1,975
| -0.3% | -$9.54K | 0.09% | 76 |
|
|
2021
Q2 | $3.66M | Sell |
571,946
-37,028
| -6% | -$237K | 0.1% | 77 |
|
|
2021
Q1 | $3.82M | Sell |
608,974
-142,869
| -19% | -$897K | 0.11% | 72 |
|
|
2020
Q4 | $5.18M | Sell |
751,843
-100
| -0% | -$689 | 0.16% | 78 |
|
|
2020
Q3 | $3.01M | Buy |
751,943
+4,308
| +0.6% | +$17.2K | 0.09% | 79 |
|
|
2020
Q2 | $2.49M | Hold |
747,635
| – | – | 0.08% | 82 |
|
|
2020
Q1 | $1.61M | Hold |
747,635
| – | – | 0.06% | 77 |
|
|
2019
Q4 | $2.36M | Hold |
747,635
| – | – | 0.07% | 65 |
|
|
2019
Q3 | $3.36M | Sell |
747,635
-75,509
| -9% | -$340K | 0.12% | 62 |
|
|
2019
Q2 | $3.92M | Buy |
+823,144
| New | +$3.92M | 0.12% | 62 |
|